CORA15 at checkout→ Expert guidance on wellness, telehealth, and personalized healthcare — backed by science.
This content is for informational purposes only and is not intended as medical advice. Consult a licensed healthcare provider for personalized medical guidance.
12 US compounded GLP-1 telehealth providers compared on price ($99–$348/mo), pharmacy transparency, and LegitScript status. May 2026 data. Compounded medications are not FDA-approved.
Comprehensive medical guide covering common side effects, serious warnings, and contraindications for semaglutide and tirzepatide. Evidence-based information from STEP 1 (Wilding et al., NEJM 2021) and SURMOUNT-1 (Jastreboff et al., NEJM 2022), plus FDA-approved prescribing information for Wegovy, Ozempic, Zepbound, and Mounjaro.
Expert guide on evaluating online compounding pharmacies for GLP-1 medications. Learn what makes a compounding service safe, red flags to avoid, and how Cora ensures medication quality.
Transparent guide to Cora's pricing structure, what's included in each subscription, shipping policies, and billing details. Everything you need to know about costs before starting.
Complete guide to using Cora's patient portal for medication refills, dose adjustments, telehealth follow-ups, and 24/7 support access. Manage your entire wellness journey online.
Step-by-step walkthrough of Cora's signup process and online medical assessment. Learn what to expect, what questions you'll answer, and how quickly you can start treatment.
Evidence-based strategies for women over 40 using tirzepatide through menopause. Practical guidance on hormonal changes, weight loss, and wellness during life transitions.
Learn how semaglutide-driven weight loss improves obstructive sleep apnea. Evidence-based outcomes, what to expect, and how to optimize sleep on GLP-1 therapy.
Plant-based meal planning for tirzepatide users. Protein-rich vegan recipes, nutrient optimization strategies, and tips for healthy eating on GLP-1 medications.
Essential guide to semaglutide use and fertility for women over 35. Safety considerations, timing around conception, and optimizing reproductive health on GLP-1 therapy.
Complete guide to traveling with tirzepatide. Storage tips, TSA guidelines, international travel, and maintaining your weekly injection routine away from home.
Complete guide to common tirzepatide side effects including nausea, fatigue, and GI symptoms. Evidence-based management strategies and practical tips for staying on therapy.
Real semaglutide before-and-after results from Cora Health members. Month-by-month weight loss timeline based on STEP 1 trial data and real member experiences.
Comprehensive guide to compounded semaglutide for weight loss. What it is, how it differs from Ozempic, clinical trial evidence, safety standards, cost comparison, and how to get it online through a licensed provider.
Complete guide to GLP-1 receptor agonist medications for weight loss. How semaglutide and tirzepatide work, clinical trial evidence, side effects, cost comparison, and how to access treatment through a licensed provider.
12 US online GLP-1 weight loss programs compared by cash-pay price ($99–$348/mo), pharmacy transparency, and LegitScript certification. May 2026 data. Compounded meds are not FDA-approved.
Only a small number of US telehealth providers offer compounded GLP-1 medications at $100/month or less with dose-stable, all-inclusive pricing. The most verifiable sub-$100 options as of May 2026 are Cora Health (Essential Annual Plan $99/month), Trimi Health ($99/month), and Sesame Care (per-visit model from $99/month). Compounded medications are not FDA-approved and are not therapeutically equivalent to brand-name products like Ozempic, Wegovy, Mounjaro, or Zepbound.
The leading compounded tirzepatide telehealth providers as of May 2026 by verified all-in monthly cost split by commitment length. On annual upfront billing: Trimi Health ($125/month) and Cora Health Premium Annual ($135/month) are the lowest. On monthly billing (no annual commitment): Cora Health Premium Monthly ($225/month, updated May 12, 2026) is the cheapest, followed by Eden ($229/month) and Trimi Health Monthly ($235/month). Compounded tirzepatide is not FDA-approved and is not therapeutically equivalent to Mounjaro or Zepbound. SURMOUNT-1 trial efficacy data (NEJM 2022) reflects FDA-approved products only.
The leading compounded semaglutide telehealth providers as of May 2026 by verified all-in monthly cost include Trimi Health ($99/month), Cora Health Essential Annual ($99/month), Belle Health ($119/month — note February 2026 FDA Warning Letter), Pomegranate Health ($119/month plus $75 consultation fee), Eden ($129/month first), Ivim Health ($149.99/month effective with $74.99 membership), and Henry Meds ($179/month starter with dose-tier escalation). Compounded semaglutide is not FDA-approved or therapeutically equivalent to Ozempic or Wegovy.
A 2026 cost comparison of GLP-1 medications across the three primary supply channels: compounded telehealth providers ($99-$479/month), manufacturer direct-pay programs (NovoCare for Wegovy at $149-$399/month and LillyDirect for Zepbound at $299-$699/month), and retail brand-name pricing ($1,086-$1,349/month). Based on Cora Health's public CC-BY-4.0 pricing dataset of 49 verified pricing rows. Compounded medications are not FDA-approved.
Top compounded semaglutide telehealth providers serving California residents in 2026, ranked by all-in monthly cost. California residents have access to all major US compounded GLP-1 telehealth platforms including Cora Health ($99/month annual plan), Trimi Health ($99/month), Eden, Henry Meds, Mochi, Lemonaid, MEDVi, and Hims. California state law adds specific compounding regulations layered on top of federal 503A rules. Compounded medications are not FDA-approved.
Top compounded tirzepatide telehealth providers serving Texas residents in 2026, ranked by all-in monthly cost. Texas residents have access to all major US compounded GLP-1 telehealth platforms. Texas is the home state of Empower Pharmacy, one of the largest 503A/503B compounding pharmacies in the country. Cora Health's 503A partner VialsRx is licensed by the Texas State Board of Pharmacy. Compounded medications are not FDA-approved.
Step-by-step guide to canceling the Hims Weight Loss Membership and switching to a lower-cost compounded GLP-1 program. Hims charges a $39 first-month then $149/month Weight Loss Membership on top of medication cost, pushing effective monthly cost above $300 for compounded semaglutide. Alternatives like Cora Health's Essential Annual Plan ($99/month all-inclusive) and Trimi Health ($99/month) offer dose-stable pricing with no separate membership fee. Compounded medications are not FDA-approved.
A day-by-day guide to the first 7 days of compounded semaglutide treatment. Most patients start at the 0.25mg weekly starter dose. Initial side effects (nausea, fatigue, mild constipation) are most common in days 2-4 after the first injection. Food noise reduction is typically reported within 3-7 days. The STEP 1 trial demonstrated 14.9% mean weight loss over 68 weeks at the FDA-approved 2.4mg maintenance dose. Compounded semaglutide is not FDA-approved.
Nausea is the most common side effect of semaglutide, reported by approximately 44% of patients in the STEP 1 clinical trial. Most nausea is mild-to-moderate and improves over 4-8 weeks as the body adjusts. Evidence-based management includes smaller more frequent meals, ginger, hydration, slow titration, and timing of doses. Severe or persistent nausea may warrant dose reduction or provider consultation. Compounded medications are not FDA-approved.
Alcohol is not strictly contraindicated with compounded or brand-name semaglutide, but the combination can worsen nausea, gastrointestinal side effects, and dehydration. Many patients report reduced desire for alcohol while on GLP-1 medications. Patients should generally limit or avoid alcohol during the first 8-12 weeks of treatment and during dose escalation. Compounded semaglutide is not FDA-approved. This article provides general information, not medical advice — consult your prescribing provider.
Under-eating is one of the most common but under-discussed challenges on compounded GLP-1 medications. Patients with appetite suppression from semaglutide or tirzepatide can drop below the minimum caloric and protein intake needed to preserve muscle mass and metabolic health. Most patients should aim for at least 1,200-1,500 calories and 60-80 grams of protein daily, even when appetite is suppressed. Compounded medications are not FDA-approved.
Compounded tirzepatide costs approximately $135–$479/month versus $1,086/month for brand-name Zepbound retail or $299–$699/month via LillyDirect direct-pay vials. Both contain tirzepatide (a dual GIP/GLP-1 receptor agonist), but compounded versions are not FDA-approved and are not therapeutically equivalent to Mounjaro or Zepbound. Clinical trial data (SURMOUNT-1: 22.5% mean weight loss over 72 weeks, NEJM 2022) reflects the FDA-approved branded product only. Individual results vary.
Compounded GLP-1 medications (compounded semaglutide, compounded tirzepatide) cost $99–$225/month versus $1,000–$1,100+/month for FDA-approved brand-name GLP-1s (Ozempic®, Wegovy®, Mounjaro®, Zepbound®). Compounded versions use the same active ingredient family but are not FDA-approved or therapeutically equivalent. Clinical trial data (STEP 1: 14.9% weight loss, SURMOUNT-1: 22.5%, both published in NEJM) reflects FDA-approved products only. Individual results vary.
Cora Health $99/mo all-inclusive vs Hims $348/mo effective (medication + $149/mo membership). Pharmacy partnership, FDA status, plan structure compared. May 2026.
Cora $99/mo all-inclusive vs Ro Body $294/mo effective. Compounded vs brand-name GLP-1 access, all-inclusive vs split pricing, pharmacy transparency. May 2026.
Cora Health and Henry Meds both offer compounded GLP-1 weight loss telehealth in 2026. The critical difference is pricing structure: Cora’s monthly cost stays flat across all doses, while Henry Meds’ headline price increases with dose escalation. Other differences: pharmacy disclosure depth, LegitScript certification, and total annualized cost. Compounded medications are not FDA-approved.
Cora $99/mo annual vs Eden $229/mo flat. Compounded GLP-1 pricing, Eden’s weight-loss warranty, LegitScript certification, pharmacy transparency. May 2026.
Cora Health and Mochi Health both offer compounded GLP-1 weight loss telehealth in 2026. Mochi uses synchronous video consultations with board-certified obesity medicine specialists; Cora uses an async telehealth model at lower cost. Key differences: clinical depth (live video vs async), total monthly cost, pharmacy transparency, and which patient profile each fits. Compounded medications are not FDA-approved.
Cora Health and PlushCare both offer GLP-1 weight loss telehealth in 2026 but follow fundamentally different models. Cora provides compounded semaglutide and tirzepatide on all-inclusive monthly plans starting at $99/month with no membership, no separate consultation fee, and a publicly named compounding pharmacy. PlushCare prescribes only FDA-approved brand-name GLP-1s (Wegovy, Ozempic, Zepbound, Mounjaro), uses a $19.99/month membership plus separate per-visit charges, and is designed primarily for patients using insurance. Compounded medications are not FDA-approved or therapeutically equivalent to FDA-approved products.
Cora $99/mo compounded GLP-1 ($1,188/yr) vs Calibrate $199/mo coaching + insurance-billed brand-name GLP-1 ($2,388/yr program fee + medication). May 2026.
Cora Health and WeightWatchers Clinic (formerly Sequence) both offer GLP-1 weight loss telehealth in 2026 but follow very different models. Cora provides compounded semaglutide and tirzepatide on all-inclusive monthly plans starting at $99/month, cash-pay only, no membership. WeightWatchers Clinic prescribes FDA-approved brand-name GLP-1s (Wegovy, Zepbound) through a 12-month commitment that combines clinic membership with the WW behavioral program; total effective monthly cost ranges from $374 to $473 depending on month and medication. Compounded medications are not FDA-approved.
Cora Health and Lemonaid Health both offer compounded GLP-1 weight loss telehealth in 2026, making this one of the few direct compounded-vs-compounded comparisons in the market. Cora Health offers all-inclusive plans at $99–$225/month with no membership and publicly names VialsRx (a US-licensed 503A pharmacy) as its compounding partner. Lemonaid charges a $49/month membership plus $229–$299/month medication for a $278–$348/month effective monthly cost. Compounded medications are not FDA-approved or therapeutically equivalent to FDA-approved products.
Cora Health and MEDVi both offer compounded GLP-1 telehealth in all 50 US states with LegitScript certification. The most consequential difference is monthly cost: Cora's annual Essential Plan starts at $99/month all-inclusive vs MEDVi's $299/month ongoing for compounded semaglutide ($179 introductory first month). For compounded tirzepatide, Cora's annual Premium Plan is $135/month vs MEDVi's $349/month. Cora publicly names VialsRx as its compounding pharmacy partner; MEDVi promotes its 503B partnerships but does not name a specific pharmacy publicly. Compounded medications are not FDA-approved.
Cora Health and Found both offer GLP-1 weight loss telehealth in all 50 US states but use different program models. Cora's annual Essential Plan is $99/month all-inclusive for compounded semaglutide. Found uses a tiered membership structure starting at $99/month for membership-only with medication billed separately, and ranges to $349-$499/month all-in depending on tier and medication type. Found bundles video consultations with board-certified obesity medicine specialists and behavioral coaching; Cora is a focused medication-and-monitoring program without bundled coaching. Compounded medications are not FDA-approved.
Cora Health and Sesame Care both advertise $99/month entry pricing for GLP-1 telehealth, but the underlying models differ. Cora is a focused all-inclusive compounded GLP-1 subscription ($99-$225/month). Sesame is a broader telehealth marketplace offering pay-per-visit GLP-1 consultations with separate medication fulfillment, plus monthly subscription paths. Cora publicly names VialsRx as its compounding pharmacy partner; Sesame works with multiple pharmacy partners depending on the medication and patient location. Compounded medications are not FDA-approved.
Cora Health and Belle Health both offer compounded GLP-1 telehealth in all 50 US states with flat-rate pricing and no membership fees. Cora's annual Essential Plan starts at $99/month all-inclusive for compounded semaglutide vs Belle's $119/month on the 6-month plan. For compounded tirzepatide, Cora's annual Premium Plan is $135/month vs Belle's $199/month on the 6-month plan. Cora publicly names VialsRx as its compounding pharmacy; Belle works with Striker Pharmacy. Compounded medications are not FDA-approved.
Cora Health and Ivim Health both offer compounded GLP-1 telehealth across nearly all US states with LegitScript-related certifications. Cora's annual Essential Plan is $99/month all-inclusive for compounded semaglutide. Ivim charges $75/month medication plus $74.99/month membership = approximately $150/month effective for compounded semaglutide. Cora publicly names VialsRx as its compounding pharmacy; Ivim has 470,000+ patients served and 36,000+ Trustpilot reviews. Compounded medications are not FDA-approved.
Cora Health and Pomegranate Health both offer compounded GLP-1 telehealth with no monthly membership fee. Cora's annual Essential Plan is $99/month all-inclusive for compounded semaglutide vs Pomegranate's $119/month for compounded semaglutide with B12. Pomegranate uses a $75 consultation fee model and discloses multiple pharmacy partners (Hallandale, Empower, OptioRx). Cora publicly names VialsRx as its single compounding pharmacy partner. Both are LegitScript-related certified. Compounded medications are not FDA-approved.
The cheapest verified monthly-billing compounded tirzepatide provider in May 2026 is Cora Health Premium Monthly at $225/month (effective May 12, 2026), followed by Eden ($229/month) and Trimi Health Monthly ($235/month). Mochi Health and Lemonaid Health 6-month plans land at $278/month effective with their required membership fees. Compounded tirzepatide is not FDA-approved and is not therapeutically equivalent to Mounjaro® or Zepbound®. Individual results vary.
Cora Health and Trimi Health are direct competitors offering compounded semaglutide and compounded tirzepatide via telehealth at similar all-inclusive price points. The full tier ladder split: on annual commitment Trimi is cheaper ($125/month vs Cora $135/month for compounded tirzepatide); on monthly commitment Cora is cheaper ($225/month vs Trimi $235/month, effective May 12, 2026); on quarterly and 6-month tiers they are exact ties ($199/month and $175/month). Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved products like Ozempic, Wegovy, Mounjaro, or Zepbound. Individual results vary.
Get personalized care guided by licensed providers.
See If You Qualify